Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BY-NCClinical, cosmetic and investigational dermatology

Integrative Analysis of Epidermal Barrier Dysfunction Regulators in Psoriasis.

4 affiliations
  1. 1Department of Medical Cosmetic, Municipal Hospital of Chifeng, Chifeng, People's Republic of China.
  2. 2Department of Dermatology, Affiliated Fuling Hospital of Chongqing University, Chongqing, People's Republic of China.
  3. 3Department of Dermatology, Municipal Hospital of Chifeng, Chifeng, People's Republic of China.
  4. 4Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.

Abstract

Introduction

Psoriasis is a chronic inflammatory skin disease characterized by keratinocyte hyperproliferation and compromised epidermal barrier function. Although tight junction disruption is a key pathological hallmark, the upstream transcriptional mechanisms driving the downregulation of core barrier proteins such as claudin-1 (CLDN1) remain insufficiently characterized.Methods

We implemented an integrative multi-omics framework combining weighted gene co-expression network analysis (WGCNA), single-cell RNA sequencing (scRNA-seq), and machine-learning algorithms to prioritize core diagnostic features in psoriasis. Upstream transcription factors regulating CLDN1 were computationally predicted using the JASPAR, hTFtarget, and KnockTF databases. The regulatory effect of E74-like ETS transcription factor 3 (ELF3) on the CLDN1 promoter was evaluated using dual-luciferase reporter assays, and the inflammatory response of the axis was examined in TNF-α-stimulated HaCaT keratinocytes via quantitative real-time PCR.Results

Machine-learning prioritization identified CLDN1 as a robust diagnostic feature that is significantly downregulated in psoriatic lesions. Multi-database integration converged on ELF3 as a candidate negative regulator of CLDN1. Dual-luciferase reporter assays demonstrated that ELF3 overexpression significantly suppressed wild-type CLDN1 promoter activity, whereas mutation of the predicted binding site abolished this repression. In TNF-α-stimulated HaCaT cells, ELF3 was markedly upregulated with a concurrent downregulation of CLDN1.Discussion

These findings suggest that ELF3 functions as a candidate transcriptional repressor of CLDN1 promoter activity and provide preliminary in vitro and computational insights into the transcriptional alterations associated with epidermal barrier disruption in psoriasis, highlighting potential avenues for restoring structural barrier integrity.

Related

  1. Epidermal Langerhans Cells Act as Neuroimmune Regulators of Pain and Itch
    K. Sakai, H. Ishida, D. Pavlenko +10
    bioRxivPreprintCC BY-NC-NDFull textNeurosciencebioRxiv
  2. Pantethine Restores Epidermal Homeostasis and Modulates Vesicle-Associated Proteins in Psoriasis.
    Passanesh Sukphopetch, Kamonpan Fongsodsri, Pornanong Aramwit +5
    Experimental dermatologyPeer-reviewedCC BYFull textImmunologyEurope PMCPMC
  3. Increased Risk of Psoriasis in Young Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Cohort Study.
    Hyun Ji Lee, Jonghee Chung, Kyungdo Han +1
    Annals of dermatologyPeer-reviewedCC BY-NCFull textImmunologyEurope PMC
  4. Regulatory T cell dysfunction and therapeutic advances in rheumatoid arthritis, psoriasis, vitiligo, and systemic lupus erythematosus
    Yanyang Liang, Haiyan Feng, Ying Wang +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossref
  5. Neurobiological mechanisms and brain network dysfunction in major depressive disorder: an integrative review
    Dina Iskakova, Burcu Yener, Altyngul Kamzanova +3
    Frontiers in integrative neurosciencePeer-reviewedCC BYFull textNeuroscienceEurope PMC
BibTeX
@article{liu2026integrative,
  title = {{Integrative Analysis of Epidermal Barrier Dysfunction Regulators in Psoriasis.}},
  author = {Yingdi Liu and Yinglin Wang and Haijun Zhu and Yang Liu and Jinyan Wang and Fangfang Li and Yuxin Zhang and Zhanli Peng and Wenxin Wang},
  journal = {Clinical, cosmetic and investigational dermatology},
  year = {2026},
  month = oct,
  doi = {10.2147/ccid.s642546},
  url = {https://europepmc.org/article/MED/42974488},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Integrative Analysis of Epidermal Barrier Dysfunction Regulators in Psoriasis.
AU  - Yingdi Liu
AU  - Yinglin Wang
AU  - Haijun Zhu
AU  - Yang Liu
AU  - Jinyan Wang
AU  - Fangfang Li
AU  - Yuxin Zhang
AU  - Zhanli Peng
AU  - Wenxin Wang
PY  - 2026
DA  - 2026/10/29
JO  - Clinical, cosmetic and investigational dermatology
DO  - 10.2147/ccid.s642546
UR  - https://europepmc.org/article/MED/42974488
AB  - Introduction  Psoriasis is a chronic inflammatory skin disease characterized by keratinocyte hyperproliferation and compromised epidermal barrier function. Although tight junction disruption is a key pathological hallmark, the upstream transcriptional mechanisms driving the downregulation of core barrier proteins such as claudin-1 (CLDN1) remain insufficiently characterized.Methods  We implemented an integrative multi-omics framework combining weighted gene co-expression network analysis (WGCNA), single-cell RNA sequencing (scRNA-seq), and machine-learning algorithms to prioritize core diagnostic features in psoriasis. Upstream transcription factors regulating CLDN1 were computationally predicted using the JASPAR, hTFtarget, and KnockTF databases. The regulatory effect of E74-like ETS transcription factor 3 (ELF3) on the CLDN1 promoter was evaluated using dual-luciferase reporter assays, and the inflammatory response of the axis was examined in TNF-α-stimulated HaCaT keratinocytes via quantitative real-time PCR.Results  Machine-learning prioritization identified CLDN1 as a robust diagnostic feature that is significantly downregulated in psoriatic lesions. Multi-database integration converged on ELF3 as a candidate negative regulator of CLDN1. Dual-luciferase reporter assays demonstrated that ELF3 overexpression significantly suppressed wild-type CLDN1 promoter activity, whereas mutation of the predicted binding site abolished this repression. In TNF-α-stimulated HaCaT cells, ELF3 was markedly upregulated with a concurrent downregulation of CLDN1.Discussion  These findings suggest that ELF3 functions as a candidate transcriptional repressor of CLDN1 promoter activity and provide preliminary in vitro and computational insights into the transcriptional alterations associated with epidermal barrier disruption in psoriasis, highlighting potential avenues for restoring structural barrier integrity.
SN  - 1178-7015
ER  -